Omnicell Inc. (OMCL)

43.30
NASDAQ : Technology Services
Prev Close 43.90
Day Low/High 42.88 / 43.75
52 Wk Low/High 38.00 / 55.40
Avg Volume 283.50K
Exchange NASDAQ
Shares Outstanding 38.86M
Market Cap 1.71B
EPS 0.60
P/E Ratio 82.83
Div & Yield N.A. (N.A)

Latest News

Omnicell To Showcase Industry-Leading Medication Management Automation Platform And Solutions At The European Association Of Hospital Pharmacists Congress

Omnicell To Showcase Industry-Leading Medication Management Automation Platform And Solutions At The European Association Of Hospital Pharmacists Congress

Scalable, Customizable, and Integrated Products to Improve Patient Safety and Reduce Costs on Display in Stand 75

Infirmary Health Adopts Omnicell's Sterile Compounding Solutions And Services

Infirmary Health Adopts Omnicell's Sterile Compounding Solutions And Services

Comprehensive turnkey solution supports safer, more cost-effective and efficient production of IVs

Omnicell Opens Center Of Excellence In Cranberry Township, Showcasing Innovation And Industry-Leading Medication Management Platform

Omnicell Opens Center Of Excellence In Cranberry Township, Showcasing Innovation And Industry-Leading Medication Management Platform

U.S. Representative Mike Kelly to Join Company Leadership for March 2 Dedication Ceremony

Omnicell's Industry-Leading Medication Management Automation Platform And Solutions To Be Featured At HIMSS18

Omnicell's Industry-Leading Medication Management Automation Platform And Solutions To Be Featured At HIMSS18

Scalable, Customizable, and Integrated Products to Improve Patient Safety and Reduce Costs on Display in Booth #1629

Pomona Valley Hospital Medical Center Adopting In-House IV Compounding With Omnicell's IV Robotics

Pomona Valley Hospital Medical Center Adopting In-House IV Compounding With Omnicell's IV Robotics

Investments in Automation Position Hospital for Long Term Savings and Patient Safety

Multiple Hospitals Adopt Omnicell's XR2 Automated Central Pharmacy System To Enhance Medication Inventory Management

Multiple Hospitals Adopt Omnicell's XR2 Automated Central Pharmacy System To Enhance Medication Inventory Management

Revolutionary Technology Automates Critical Workflows, Refocusing Pharmacists' Time on Clinical Activities

Omnicell's Automated Medication Dispensing System Receives Top KLAS Award For The 12th Consecutive Year

Omnicell's Automated Medication Dispensing System Receives Top KLAS Award For The 12th Consecutive Year

Company Also Recognized as Category Leader in Carousels, i.v.STATION Most Improved Medical Equipment Product

Dartmouth-Hitchcock Health Selects Omnicell's Performance Center To Help Develop Centralized Pharmacy Service Center

Dartmouth-Hitchcock Health Selects Omnicell's Performance Center To Help Develop Centralized Pharmacy Service Center

Enhanced Visibility and Ongoing Services Optimizes Inventory Management and Medication Ordering Across the Health System

UPMC Chooses Revolutionary Technology From Omnicell To Elevate And Automate Pharmacy

UPMC Chooses Revolutionary Technology From Omnicell To Elevate And Automate Pharmacy

Central Pharmacy and IV Compounding Solutions Enhance Patient, Staff Experience

Hacettepe University Oncology Hospital Introduces Omnicell I.v.STATION ONCO Robots To Chemotherapy Unit

Hacettepe University Oncology Hospital Introduces Omnicell I.v.STATION ONCO Robots To Chemotherapy Unit

IV Robotics Helps Increase Patient and Provider Safety During Compounding of Hazardous Chemotherapy Drugs in Turkey Healthcare Facility

Omnicell Introduces Revolutionary New Solution To Automate Critical Workflows In Central Pharmacy

Omnicell Introduces Revolutionary New Solution To Automate Critical Workflows In Central Pharmacy

XR2 Automated Central Pharmacy System Enhances Control, Efficiency, and Safety for Medication Inventory Management

Omnicell Announces Winners Of Inaugural "Inspired By Care" Award

Omnicell Announces Winners Of Inaugural "Inspired By Care" Award

Texas Children's Hospital and UPMC Pharmacy Director Honored for Leadership

Omnicell Supports Global Charity Mercy Ships By Donating Next Generation XT Series Equipment And Funds

Omnicell Supports Global Charity Mercy Ships By Donating Next Generation XT Series Equipment And Funds

Automated Dispensing Systems Will Enable Improved Inventory Management Aboard Medical Ship That Provides Life-Changing Care for Those in Need

Short Interest Decreases By 10.8% For OMCL

Short Interest Decreases By 10.8% For OMCL

The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 345,543 share decrease in total short interest for Omnicell Inc , to 2,866,560, a decrease of 10.76% since 10/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Texas Children's Hospital Implements Omnicell Performance Center And Upgrades Medication Management Automation

Texas Children's Hospital Implements Omnicell Performance Center And Upgrades Medication Management Automation

Combination of Professional Pharmacy Services, Hardware, and Software Helps Create Consistency and Improve Performance Across Health System

Omnicell Launches New IVX Workflow Solution To Enhance Safety, Accuracy, And Efficiency In Sterile Compounding

Omnicell Launches New IVX Workflow Solution To Enhance Safety, Accuracy, And Efficiency In Sterile Compounding

Mass General and Brigham and Women's Adopt New Technology

Hackensack Meridian Health Expands Contract With Omnicell For Medication Management Technology

Hackensack Meridian Health Expands Contract With Omnicell For Medication Management Technology

Newly expanded health system to implement cohesive medication dispensing solutions in five additional facilities

Signs of Consolidation After Buying Surge

Tesla bounces despite bad news.

Omnicell Reaches Analyst Target Price

Omnicell Reaches Analyst Target Price

In recent trading, shares of Omnicell Inc have crossed above the average analyst 12-month target price of $51.14, changing hands for $52.30/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Short Interest Decreases By 10.8% For OMCL

Short Interest Decreases By 10.8% For OMCL

The most recent short interest data has been released for the 08/15/2017 settlement date, which shows a 419,471 share decrease in total short interest for Omnicell Inc , to 3,450,765, a decrease of 10.84% since 07/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ATRO, BLL, CCE, CSII, EGN, EMR, HCI, IMPV, K, MANT, MLCO, MX, OI, RDS.A, RDS.B, TPRE, USCR, WMC Downgrades: CCO, CLF, GCAP, INCY, KMPR, OMCL, OMI, SHEN, SWIR, UEPS Initiations: ORMP Read on to get TheStreet Quant Ratings' detailed report:

Short Interest In Omnicell Increases 15.6%

The most recent short interest data has been released for the 03/15/2017 settlement date, which shows a 538,618 share increase in total short interest for Omnicell Inc , to 3,984,297, an increase of 15.63% since 02/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALKS, CCU, CRAY, CRNT, DX, ELMD, ESSA, NLY, OMCL, XEC Downgrades: ETR, RDCM Initiations: SGLB Read on to get TheStreet Quant Ratings' detailed report:

Omnicell Stock Sees Short Interest Increase 12.2%

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 277,900 share increase in total short interest for Omnicell Inc , to 2,555,167, an increase of 12.20% since 01/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

TheStreet Quant Rating: C+ (Hold)